抗体

抗胱氨酸-天冬氨酸蛋白酶9抗体

MBS175609

0.1毫克

245美元

多克隆

兔

未共轭

免疫印迹, 免疫组化, 免疫组化-石蜡切片

抗体

抗胱氨酸-天冬氨酸蛋白酶9抗体

胱氨酸-天冬氨酸蛋白酶9

Caspase-9(CASP-9); caspase 9, apoptosis-related cysteine peptidase; APAF 3 antibody; APAF-3 antibody; APAF3 antibody; Apoptosis related cysteine peptidase antibody; Apoptotic protease activating factor 3 antibody; Apoptotic protease Mch 6 antibody; Apoptotic protease Mch-6 antibody; Apoptotic protease-activating factor 3 antibody; CASP 9 antibody; CASP-9 antibody; CASP9 antibody; CASP9_HUMAN antibody; Caspase 9 apoptosis related cysteine peptidase antibody; Caspase 9 Dominant Negative antibody; Caspase 9c antibody; Caspase-9 antibody; Caspase-9 subunit p10 antibody; Caspase9 antibody; ICE LAP6 antibody; ICE like apoptotic protease 6 antibody; ICE-LAP6 antibody; ICE-like apoptotic protease 6 antibody; MCH6 antibody; RNCASP9 antibody

Caspase-9; Caspase-9; caspase-9; apoptotic protease MCH-6; ICE-like apoptotic protease 6; apoptotic protease activating factor 3; protein phosphatase 1, regulatory subunit 56; caspase 9, apoptosis-related cysteine peptidase; Apoptotic protease Mch-6; Apoptotic protease-activating factor 3; APAF-3; ICE-like apoptotic protease 6; ICE-LAP6

CASP9

CASP9;CASP9;MCH6;APAF3;APAF-3;PPP1R56;ICE-LAP6;MCH6;CASP-9;APAF-3;ICE-LAP6

CASP9_HUMAN

多克隆

IgG

兔

人类

416

免疫原亲和纯化

冻干

At -20 degree C for one year. After reconstitution, at 4 degree C for one month. It can also be aliquotted and stored frozen at -20 degree C for a longer time. Avoid repeated freezing and thawing.

免疫印迹(免疫印迹), 免疫组化(免疫组化)石蜡

Immunogen: A synthetic peptide corresponding to a sequence in the middle region of human Caspase 9 (183-198aa SNIDCEKLRRRFSSLH).

Contents: Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. Reconstitution: Add 0.2ml of distilled water will yield a concentration of 500ug/ml.

Description: Rabbit IgG polyclonal antibody for Caspase-9(CASP9) detection. Tested with WB, IHC-P in Human. Background: CASP9(CASPASE9), also called APAF3, is an initiator caspase, encoded by the CASP9 gene. The CASP9 gene is mapped to chromosome 1p36.3-p36.1 by FISH. CASP9 is identified as a member of the caspase family that participates in caspase-3 activation in vitro. And it also regarded as the most upstream member of the apoptotic protease cascade that is triggered by cytochrome c and dATP. Its genomic coordinates(GRCh37) is 1:15,818,768-15,851,284. The crystal structure of CASP9 is complex with the BIR3 in an inhibitory domain of XIAP at 2.4-angstrom resolution and the CASP9 gene contains 9 exons and spans approximately 35 kb of genomic DNA. Caspase-9 and APAF1 bind to each other via their respective NH2-terminal CED-3 homologous domains in the presence of cytochrome c and dATP, an event that leads to caspase-9 activation. CASP9 activity increases dramatically upon association with the apoptosome complex. And the majority of Casp9 knockout mice died perinatally with a markedly enlarged and malformed cerebrum caused by reduced apoptosis during brain development.

28558771

P55211.3

P55211

36,564 Da

AGE/RAGE Pathway (698754); AKT Phosphorylates Targets In The Cytosol Pathway (106475); Activation Of Caspases Through Apoptosome-mediated Cleavage Pathway (105672); Adaptive Immune System Pathway (366160); Alzheimer's Disease Pathway (83097); Alzheimer's Disease Pathway (509); Alzheimers Disease Pathway (672448); Amyotrophic Lateral Sclerosis (ALS) Pathway (920975); Amyotrophic Lateral Sclerosis (ALS) Pathway (83099); Amyotrophic Lateral Sclerosis (ALS) Pathway (511)

This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]

CASP9: a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. This protein is processed by caspase APAF1; this step is thought to be one of the earliest in the caspase activation cascade. Alternative splicing results in two isoforms. Protein type: Apoptosis; Protease; EC 3.4.22.62. Chromosomal Location of Human Ortholog: 1p36.21. Cellular Component: mitochondrion; nucleus; cytosol; apoptosome. Molecular Function: peptidase activity; protein binding; cysteine-type endopeptidase activity; enzyme activator activity; protein kinase binding; SH3 domain binding. Biological Process: epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; phosphoinositide-mediated signaling; nerve growth factor receptor signaling pathway; apoptosis; positive regulation of apoptosis; DNA damage response, signal transduction; response to lipopolysaccharide; proteolysis; response to estradiol stimulus; response to antibiotic; DNA damage response, signal transduction resulting in induction of apoptosis; positive regulation of neuron apoptosis; response to cobalt ion; innate immune response; caspase activation via cytochrome c; platelet formation; response to DNA damage stimulus; aging

0.1毫克

245美元